RCKT
NASDAQ · Biotechnology
Rocket Pharmaceuticals Inc
$3.37
-0.13 (-3.71%)
RCKT News30 articles
Rocket Lab Slides 4.8% as Iridium Deal Faces Regulatory Hurdles
Rocket Lab shares dropped 4.8% Friday after a $1.94B capital raise, with Iridium deal still pending FCC review and shareholder vote.
Rocket Companies Faces Investor Skepticism as Mortgage Rates Rebound
Rocket Companies (RKT) shares dropped 2.9% as mortgage rates rose to 6.95%, raising concerns about origination volume despite a $2 trillion servicing book.
Rocket Lab's New Solar Cell: Supply Chain Win, Valuation Questions Remain
Rocket Lab's new solar cell solves a supply chain problem but not its valuation. Shares rose 2.5% as the company unveiled IMM Apex.
Rocket Lab CFO Sells $8.78M in Shares via Pre-Arranged Plan
Rocket Lab CFO Adam Spice sold $8.78 million in shares, but the sale was pre-arranged and his common stake remains unchanged. The move is part of routine option exercise and diversification.
ARB Token Rockets 38% as Arbitrum's Economic Engine Outpaces Treasury Revenue
ARB token jumped 38% to $0.179 as Arbitrum's H1 ecosystem GDP hit $206M, but DAO income was only $6.19M. Robinhood's chain adds revenue, yet token holders await value accrual.
Dash Rockets 30% as Trading Volume Hits 55% of Market Cap
Dash jumped 30.5% as 24-hour trading volume reached 54.6% of its market value, signaling intense speculative activity. Analysts debate whether the move is sustainable.
Scorpio Gold ADS Rockets 129% on Nasdaq Debut, Premium Widens
Scorpio Gold ADS (SGLD) skyrocketed 129% to $11.66, trading at a 50% premium to TSX-V shares. However, cash reserves are thin, raising funding concerns.
Quoin Rockets 42% on QRX003 Data, Unveils $50M Funding Plan
Quoin shares jumped 41.8% after QRX003 met its primary endpoint in an interim analysis. The company also announced a $50 million fundraising.
Propanc Biopharma Rockets 151% on Promising PRP Pancreatic Cancer Data
Propanc Biopharma (PPCB) shares jumped 151% after PRP reduced tumor growth by over 90% in pancreatic cancer models, with volume nearly 20 times normal.
Volato Stock Skyrockets 62% on $500M AI Infrastructure Merger Deal
Volato (SOAR) shares jumped 62% after announcing a $500M merger with AI infrastructure firm Alignment Engine, a deal 38 times its market cap.
Mortgage Rates Dip Slightly; Rocket Faces Refinancing Hurdle
Mortgage rates eased to 6.65%, saving just $5.30 monthly on a $400k loan. Refinance demand remains weak, pressuring Rocket Companies (RKT).
FreeCast Shares Skyrocket 144% on Record Volume, Yet No Fresh Catalysts Emerge
FreeCast (CAST) jumped 144% to $2.10 on 127.7 million shares, 11x its average volume. No new disclosures accompanied the surge, leaving traders to speculate on the catalyst.
Rocket Stock Slips 2.6% as Modest Rate Cut Offers Little Relief
Rocket Companies shares dropped 2.6% as a 7-basis-point decline in 30-year mortgage rates cuts a typical monthly payment by only $16, underscoring limited near-term housing relief.
Rocket Shares Edge Up as Mortgage Rates Hit 3-Week Low
Rocket Companies (RKT) edged up 0.8% in premarket trading as mortgage rates dropped to a three-week low, but the company's Q3 revenue outlook remains down 5.8% from Q2.
Rocket Shares Rise as Cooler Inflation Trims Mortgage Costs
Rocket Companies (RKT) advanced 1.7% premarket as a softer CPI report cut mortgage rates, saving $16 monthly on a $400,000 loan. The average 30-year rate fell to 6.72%.
Rocket Lab Stock Climbs on Record Backlog, Neutron Timing Weighed
Rocket Lab (RKLB) shares rose 1.2% to $80.99 premarket, buoyed by a record $2.36B backlog and strong Q2 revenue, though Neutron launch timing remains a concern.
Rocket Lab Slides 7% as Neutron Delay, Margin Concerns Offset Record Revenue
Rocket Lab shares dropped 7% after hours as investors focused on Neutron's delayed timeline and soft margin forecast, despite a record revenue quarter.
Rocket Lab and AST SpaceMobile Rise Premarket Ahead of Q2 Earnings
Rocket Lab and AST SpaceMobile shares rose in premarket trading ahead of their Q2 earnings reports. ASTS faces a challenging revenue target for the second half.
Rocket Lab Stock Soars 27.5% Ahead of Q2 Earnings: Key Levels to Watch
Rocket Lab (NASDAQ:RKLB) shares jumped 27.5% last week to $82.83, adding $10.7B in market value before Q2 earnings. Analysts expect revenue of $231.62M and a per-share loss of $0.06.
Rocket Lab's Post-Surge Rally Faces Earnings Reality Check
Rocket Lab (RKLB) shares jumped 27.5% to $82.83 before Q2 earnings, but valuation demands strong guidance. Iridium deal and Neutron progress are key.
Rocket Companies Bounces Back on Servicing Deal, Record Refi Share
Rocket Companies shares recovered 3.8% to $13.72 after a $795M servicing deal, while Q2 revenue doubled and refinance share hit an all-time high.
MasterBeef Shares Rocket 121% on Thin Float as Volume Hits 26M
MasterBeef (NASDAQ:MB) shares soared 121% on August 7, 2026, as trading volume hit 26.1 million shares, surpassing the total outstanding. The surge occurred despite no recent company news.
Rocket After-Hours Slide Masks Record Mortgage Share
Rocket Companies (RKT) shares fell after-hours as Q2 revenue missed despite record mortgage share, with lower-margin channels pressuring revenue.
Rocket Lab Soars 4% on $663M Space Force Deals, Neutron in Focus
Rocket Lab shares climbed 4.1% to $77.89 after winning $663M in Space Force contracts, with Neutron playing a key role. Q2 earnings due Monday.
Paranovus Rockets 119% on $33M Heyviva Deal, Market Cap Dwarfed
PAVS stock jumped over 119% premarket after a $33M Heyviva asset purchase, which is 7.8 times its Wednesday market cap. The deal raises questions about valuation and financing.
Rocket Lab Stock Wavers Despite $397M Space Force Win as Neutron Test Approaches
Rocket Lab's $397M Space Force award fails to lift shares as investors focus on Neutron test timing and contract economics ahead of Q2 earnings.
Autonomix Medical Stock Rockets 434% on Delayed Patent Disclosure
Autonomix Medical (AMIX) shares skyrocketed 434% on Tuesday following a delayed patent announcement. The stock later fell 37.7% in premarket trading.
Autonomix Medical Stock Skyrockets 400% on Patent News, but Timing Raises Questions
Shares of Autonomix Medical (NASDAQ:AMIX) jumped nearly 400% on Tuesday following a patent update, though the patent was granted in October 2025. The rally also brought warrants into the money.
Mangoceuticals Rockets 173% on Nuclear Merger; Existing Holders Left with 4%
Mangoceuticals (MGRX) shares soared 173.5% to $0.8029 after announcing a reverse merger with Nuclea Energy, with existing shareholders retaining only 4% pre-PIPE.
Focus Universal Stock Rockets 651% on AI Debut, But Skeptics Abound
Focus Universal (FCUV) soared 651% after unveiling an AI document platform, but the move is driven by speculation rather than fundamentals, with no revenue details disclosed.